EZN-2208

· Enzon Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for EZN-2208, covering 2009-10-09 to 2011-09-20. Get the full timeline:

Most recent: Clinical Trial Update: A Study of EZN-2208 Administered With or Without Cetuximab in Patients With Metastatic Colorectal Carcinoma [Phase 2]

See pricing